US EditionPublished • loading... • Updated
United Therapeutics Reports Early Success For External Liver Support In Acute Failure
Summary by BizToc
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
United Therapeutics Reports Early Success For External Liver Support In Acute Failure
United Therapeutics Corp. (NASDAQ:UTHR) on Monday shared results from its phase 1 study of miroliverELAP, an external liver assist product, in patients with acute forms of liver failure. Developed by Miromatrix Medical, a wholly owned subsidiary of United Therapeutics, miroliverELAP consists of an…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
